GHCM
PMC

Glen Harbor Capital Management’s PharMerica Corporation PMC Stock Holding History

Glen Harbor Capital Management’s Portfolio PMC Stock Details PMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-1,856
Closed -$49K – 1301
2017
Q2 		$49K Buy
1,856
+912
+97% +$22.4K ﹤0.01% 1202
2017
Q1 		$22K Sell
944
-288
-23% -$7.11K ﹤0.01% 1232
2016
Q4 		$31K Buy
+1,232
New +$31.1K ﹤0.01% 1160

Other funds holding PMC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Glen Harbor Capital Management's PMC Position: Q3 2017 in Review

Glen Harbor Capital Management sold out of PharMerica Corporation (PMC) in Q3 2017, closing a stake of 1,856 shares — an estimated $49K sold.

Glen Harbor Capital Management first reported a position in PMC in Q4 2016 and held it in 3 quarters. The position peaked at $49K in Q2 2017. 150 funds tracked by Wall St. Rank hold PMC as of Q3 2017.

  • Glen Harbor Capital Management reported no remaining PharMerica Corporation position as of Q3 2017 after selling out during the quarter.
  • Glen Harbor Capital Management sold 1,856 PharMerica Corporation shares in Q3 2017, an estimated $49K.
  • Glen Harbor Capital Management first reported a position in PharMerica Corporation in Q4 2016 and held it in 3 quarters.
  • Glen Harbor Capital Management's PharMerica Corporation position peaked at $49K in Q2 2017.
  • 150 funds tracked by Wall St. Rank held PharMerica Corporation as of Q3 2017.

Based on Glen Harbor Capital Management's 13F filing for Q3 2017, filed 14 Nov 2017.